The Encyclopedia of ADDICTIVE DRUGS

Total Page:16

File Type:pdf, Size:1020Kb

The Encyclopedia of ADDICTIVE DRUGS The Encyclopedia of ADDICTIVE DRUGS RICHARD LAWRENCE MILLER GREENWOOD PRESS The Encyclopedia of ADDICTIVE DRUGS The Encyclopedia of ADDICTIVE DRUGS RICHARD LAWRENCE MILLER GREENWOOD PRESS Westport, Connecticut • London Library of Congress Cataloging-in-Publication Data Miller, Richard Lawrence. The encyclopedia of addictive drugs / Richard Lawrence Miller. p. cm. Includes bibliographical references and index. ISBN 0–313–31807–7 (alk. paper) 1. Drugs of abuse—Handbooks, manuals, etc. I. Title. RM316.M555 2002 615'.78—dc21 2002075332 British Library Cataloguing in Publication Data is available. Copyright ᭧ 2002 by Richard Lawrence Miller All rights reserved. No portion of this book may be reproduced, by any process or technique, without the express written consent of the publisher. Library of Congress Catalog Card Number: 2002075332 ISBN: 0–313–31807–7 First published in 2002 Greenwood Press, 88 Post Road West, Westport, CT 06881 An imprint of Greenwood Publishing Group, Inc. www.greenwood.com Printed in the United States of America TM The paper used in this book complies with the Permanent Paper Standard issued by the National Information Standards Organization (Z39.48–1984). 10987654321 Contents Introduction 1 Drug Types 11 Alphabetical Listings of Drugs 31 Sources for More Information 445 Drug Name Index 453 Subject Index 489 Introduction The Encyclopedia of Addictive Drugs will save readers many hours of time that would otherwise be spent tracking down basic facts in science journals and libraries. This book is useful to a wide variety of persons—from a student doing a term paper to reporters preparing a story, from parents reading that story to a narcotics law enforcement officer needing extra information for a public presentation. In writing this book the approach has been multidisciplinary, meaning that perspectives from several fields of research have been pulled together. The same substance may mean different things to a chemist, a biologist, a physi- cian, or an anthropologist. Thousands of scientific reports were sifted for in- formation and concepts that will be meaningful to readers seeking basic information about specific substances and about drugs in general. The core of this book is an alphabetical listing of substances. Some are not ordinarily thought of as drugs, but all have been misused in ways indistin- guishable from drug abuse. While information in the individual listings and elsewhere may refer to various physical effects, such information does not constitute medical advice. Anyone with a medical difficulty needs to consult a medical practitioner, not this book. In addition to meaty information about what drugs do, this book includes trivia that might interest, for example, a student preparing a report or a home- work assignment. For instance, some individual listings of drugs mention little-known military usage that might intrigue teens interested in the armed forces. Some experiments are mentioned not because they are necessary to know about, but because they might add depth to a term paper or inspire a student to pursue a new angle. Material about effects on pregnancy is inher- ently important but might also have special interest for female readers. In addition to alphabetical listings of substances, this book includes a section about drug types in which substances are arranged in general categories, such 2 The Encyclopedia of Addictive Drugs as stimulants, with further grouping by classes of stimulants (amphetamine, anorectic, cocaine, pyridine alkaloid). Such an arranging of drugs puts them in a broader context of information. A chemist knows that a certain element has particular characteristics because of its place in the periodic table, and a biologist knows that a certain organism will have particular characteristics because of its species classification. A reader of this book can automatically glean information about an individual substance because of the way it is clas- sified. For example, everything said in this book about stimulants applies to the class of stimulants known as amphetamines; everything said about am- phetamines applies to the particular drug methamphetamine. (Substances printed in bold have main entries in this book’s alphabetical section.) A reader familiar with basics about stimulants and who only needs a few specifics about methamphetamine can quickly find those details. A reader who needs to un- derstand more about the general nature of stimulants can find that back- ground information as well. Persons desiring to go deeper than the summaries of scientific information in alphabetical entries can consult reliable sources listed at the end of each entry. Many of those sources list still more references. This book concludes with a guide to finding general information about drugs. Here readers are directed not only to ostensibly neutral sources of information but also to sources taking explicit and differing stances on various aspects of drug use. The index lists street names and other alternate names (used in various communities at various times), giving page numbers where information can be found about those drugs. Descriptions of individual drugs in the alphabetical section of this book present the scientific consensus about those substances, based mainly upon reports from refereed science journals. A refereed journal is one that does not merely accept an author’s word but instead has the articles critiqued and approved by assorted experts prior to publication. Articles in such journals are fundamental sources of scientific information. Although findings reported in this book come from scientific investigations around the world, not every- one agrees with what scientists discover about drugs. Sometimes scientists themselves disagree with one another. The history of science is filled with detection of errors, and future research will no doubt provide new under- standings of these drugs. This book, however, presents scientific consensus concerning these drugs as the twenty-first century begins. DRUG ABUSE Drug abuse is an emotionally charged topic involving more than facts about pharmaceuticals. Personal and moral values are involved, as are fears that sometimes transform into anger. The author of this book has studied drug abuse questions since the 1980s; visited with prosecutors, judges, and health care givers, along with drug abusers and their families; drafted drug control legislation introduced by Republican and Democratic legislators; testified be- fore legislative committees; and given public presentations. In all settings, facts have rapidly disappeared in discussion of the topic. For most of the twentieth century, addiction was considered a physical ef- Introduction 3 fect of some drugs. If a drug failed to produce physical symptoms associated with addiction, the substance was classified as nonaddictive. In the 1980s, however, some researchers began arguing that addiction could exist without associated physical symptoms, that mental craving alone was enough to power addiction.1 An important boost to acceptance of that concept came in 1987 when the American Psychiatric Association declared that “cocaine de- pendence” did not require physical dependence for diagnosis.2 The APA stated, “Continuing use of cocaine appears to be driven by persistent craving and urges for the substance rather than attempts to avoid or alleviate with- drawal symptoms.”3 That approach yielded a broader understanding: that people could be addicted to things other than drugs, a new and controversial concept but one that was becoming more accepted as the twenty-first century began. Regardless of whether addiction can be more of a mental process than a physical one, the likelihood of a user developing a harmful relationship with drugs is greater with some substances than with others. The harm may be physical. The harm may be disruption of a user’s life. Experience shows, for example, that cocaine is far more risky to use than caffeine. Some drugs can be used so much that they and a person’s body develop what may be called a physical resonance. That is not a standard drug abuse term, but it communicates the concept more vividly than other terminology. Resonance means that an individual’s body has adapted to the drug in such a way that stopping use of the drug makes a person feel ill. Symptoms depend on the drug and can range from a runny nose to convulsions. Not all drugs can produce such a state, but those that can are traditionally called addictive. Indeed, appearance or nonappearance of an “abstinence” or “withdrawal” syndrome of illness upon sudden end to drug dosage used to be considered a definitive test of whether a drug is addictive and whether a user is an addict. Some specialists might use the term neuroadaptation for the mechanism that creates resonance, but here more conservative language that asserts less about roles of the brain and nervous system will be used. Resonance is typically, and somewhat misleadingly, called “dependence” by many persons. An addict who temporarily feels sick upon stopping a drug but who later feels better is not really “dependent” on it, in the ordinary dictionary sense of that word’s meaning. Granted, physical dependence upon a drug is possible, in the dictionary sense, regardless of whether the under- lying mechanism is neuroadaptation. An example is a diabetic who needs insulin. Cutting off insulin supply would make the diabetic sicker and sicker, so the person truly is dependent on the drug. Its presence is necessary for good health. Normally, however, that is not what is meant by saying a drug abuser is dependent on a substance; rather, one means the abuser will feel temporarily ill if dosage suddenly stops. Nonetheless, some drug addictions can involve the dictionary meaning of dependence. For example, persons ex- tremely addicted to alcohol or barbiturates can die if cut off from their supply. Death typically comes from cascading problems culminating in convulsions. That dismal outcome is uncommon but possible. In addition, dependence is sometimes used in contexts making it synonymous with addiction, perhaps referring to persons undergoing treatment to break dependence on some drug 4 The Encyclopedia of Addictive Drugs they crave and are unable to stop taking.
Recommended publications
  • Federal Register/Vol. 70, No. 42/Friday, March 4, 2005
    Federal Register / Vol. 70, No. 42 / Friday, March 4, 2005 / Notices 10677 Drug Schedule Drug Schedule Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, Cathinone (1235) .......................... I Alpha-Methylfentanyl (9814) ........ I the above named company is granted Methcathinone (1237) .................. I Acetyl-alpha-methylfentanyl I registration as a bulk manufacturer of N-Ethylamphetamine (1475) ........ I (9815). the basic classes of controlled N,N-Dimethylamphetamine (1480) I Beta-hydroxyfentanyl (9830) ........ I substances listed. Aminorex (1585) ........................... I Beta-hydroxy-3-methylfentanyl I 4-7Methylaminorex (cis isomer) I (9831). Dated: Febuary 22, 2005. (1590). Alpha-Methylthiofentanyl (9832) ... I William J. Walker, Gamma hydroxybutyric acid I 3–Methylthiofentanyl (9833) ......... I Deputy Assistant Administrator, Office of Thiofentanyl (9835) ...................... I (2010). Diversion Control, Drug Enforcement Amphetamine (1100) .................... II Methaqualone (2565) ................... I Administration. Alpha-Ethyltryptamine (7249) ....... I Methamphetamine (1105) ............ II Lysergic acid diethylamide (7315) I Phenmetrazine (1631) .................. II [FR Doc. 05–4205 Filed 3–3–05; 8:45 am] Tetrahydrocannabinols (7370) ..... I Methylphenidate (1724) ................ II BILLING CODE 4410–09–P Mescaline (7381) .......................... I Ambobarbital (2125) ..................... II 3,4,5-Trimethoxyamphetamine I Pentobarbital (2270) ..................... II (7390).
    [Show full text]
  • Appendix Color Plates of Solanales Species
    Appendix Color Plates of Solanales Species The first half of the color plates (Plates 1–8) shows a selection of phytochemically prominent solanaceous species, the second half (Plates 9–16) a selection of convol- vulaceous counterparts. The scientific name of the species in bold (for authorities see text and tables) may be followed (in brackets) by a frequently used though invalid synonym and/or a common name if existent. The next information refers to the habitus, origin/natural distribution, and – if applicable – cultivation. If more than one photograph is shown for a certain species there will be explanations for each of them. Finally, section numbers of the phytochemical Chapters 3–8 are given, where the respective species are discussed. The individually combined occurrence of sec- ondary metabolites from different structural classes characterizes every species. However, it has to be remembered that a small number of citations does not neces- sarily indicate a poorer secondary metabolism in a respective species compared with others; this may just be due to less studies being carried out. Solanaceae Plate 1a Anthocercis littorea (yellow tailflower): erect or rarely sprawling shrub (to 3 m); W- and SW-Australia; Sects. 3.1 / 3.4 Plate 1b, c Atropa belladonna (deadly nightshade): erect herbaceous perennial plant (to 1.5 m); Europe to central Asia (naturalized: N-USA; cultivated as a medicinal plant); b fruiting twig; c flowers, unripe (green) and ripe (black) berries; Sects. 3.1 / 3.3.2 / 3.4 / 3.5 / 6.5.2 / 7.5.1 / 7.7.2 / 7.7.4.3 Plate 1d Brugmansia versicolor (angel’s trumpet): shrub or small tree (to 5 m); tropical parts of Ecuador west of the Andes (cultivated as an ornamental in tropical and subtropical regions); Sect.
    [Show full text]
  • Did Internet-Purchased Diet Pills Cause Serotonin Syndrome?
    Did Internet-purchased diet pills cause serotonin syndrome? Phentermine also may have increased patient’s neuroleptic malignant syndrome risk s. G, age 28, presents to a tertiary® careDowden hospital Health Media with altered mental status. Six weeks ago she Mstarted taking phentermine, 37.5 mg/d, to lose weight. Her body mass indexCopyright is 24 kg/mFor2 (normal personal range), use only and she obtained the stimulant agent via the Internet. Her family reports Ms. G was very busy in the past week, staying up until 2 AM cleaning. They say she also was irritable with her 5-year-old son. Two days ago, Ms. G complained of fatigue and nausea without emesis. She went to bed early and did not awaken the next morning. Her sister found her in bed, minimally re- DIONISI sponsive to verbal stimuli, and brought her to the hospital. Patients have used phentermine as a weight-reducing IMAGES/SANDRA GETTY agent since the FDA approved this amphetamine-like © compound in 1960.1 Phentermine’s mechanism of ac- tion is thought to involve dopaminergic, noradrenergic, Kyoung Bin Im, MD and serotonergic effects.2 Stimulation of norepineph- Chief resident Internal medicine and psychiatry combined residency program rine (NE) release is its most potent effect, followed Departments of internal medicine and psychiatry by NE reuptake inhibition, stimulation of dopamine Jess G. Fiedorowicz, MD (DA) release, DA reuptake inhibition, stimulation of Associate in psychiatry serotonin (5-HT) release, and 5-HT reuptake inhibition Department of psychiatry (weak).3 Roy J. and Lucille A. Carver College of Medicine Because phentermine could in theory cause serotonin 4 University of Iowa syndrome, its use is contraindicated with monoamine Iowa City oxidase inhibitors (MAOIs) and not recommended with selective serotonin reuptake inhibitors (SSRIs).5 One case report describes an interaction between fl uox- etine and phentermine that appears consistent with se- rotonin syndrome.6 We are aware of no case reports of Current Psychiatry serotonin syndrome caused by phentermine alone.
    [Show full text]
  • Medical Review Officer Manual
    Department of Health and Human Services Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention Medical Review Officer Manual for Federal Agency Workplace Drug Testing Programs EFFECTIVE OCTOBER 1, 2010 Note: This manual applies to Federal agency drug testing programs that come under Executive Order 12564 dated September 15, 1986, section 503 of Public Law 100-71, 5 U.S.C. section 7301 note dated July 11, 1987, and the Department of Health and Human Services Mandatory Guidelines for Federal Workplace Drug Testing Programs (73 FR 71858) dated November 25, 2008 (effective October 1, 2010). This manual does not apply to specimens submitted for testing under U.S. Department of Transportation (DOT) Procedures for Transportation Workplace Drug and Alcohol Testing Programs (49 CFR Part 40). The current version of this manual and other information including MRO Case Studies are available on the Drug Testing page under Medical Review Officer (MRO) Resources on the SAMHSA website: http://www.workplace.samhsa.gov Previous Versions of this Manual are Obsolete 3 Table of Contents Chapter 1. The Medical Review Officer (MRO)........................................................................... 6 Chapter 2. The Federal Drug Testing Custody and Control Form ................................................ 7 Chapter 3. Urine Drug Testing ...................................................................................................... 9 A. Federal Workplace Drug Testing Overview..................................................................
    [Show full text]
  • The Stimulants and Hallucinogens Under Consideration: a Brief Overview of Their Chemistry and Pharmacology
    Drug and Alcohol Dependence, 17 (1986) 107-118 107 Elsevier Scientific Publishers Ireland Ltd. THE STIMULANTS AND HALLUCINOGENS UNDER CONSIDERATION: A BRIEF OVERVIEW OF THEIR CHEMISTRY AND PHARMACOLOGY LOUIS S. HARRIS Dcparlmcnl of Pharmacology, Medical College of Virginia, Virginia Commonwealth Unwersity, Richmond, VA 23298 (U.S.A.) SUMMARY The substances under review are a heterogenous set of compounds from a pharmacological point of view, though many have a common phenylethyl- amine structure. Variations in structure lead to marked changes in potency and characteristic action. The introductory material presented here is meant to provide a set of chemical and pharmacological highlights of the 28 substances under con- sideration. The most commonly used names or INN names, Chemical Abstract (CA) names and numbers, and elemental formulae are provided in the accompanying figures. This provides both some basic information on the substances and a starting point for the more detailed information that follows in the individual papers by contributors to the symposium. Key words: Stimulants, their chemistry and pharmacology - Hallucinogens, their chemistry and pharmacology INTRODUCTION Cathine (Fig. 1) is one of the active principles of khat (Catha edulis). The structure has two asymmetric centers and exists as two geometric isomers, each of which has been resolved into its optical isomers. In the plant it exists as d-nor-pseudoephedrine. It is a typical sympathomimetic amine with a strong component of amphetamine-like activity. The racemic mixture is known generically in this country and others as phenylpropanolamine (dl- norephedrine). It is widely available as an over-the-counter (OTC) anti- appetite agent and nasal decongestant.
    [Show full text]
  • Nightshade”—A Hierarchical Classification Approach to T Identification of Hallucinogenic Solanaceae Spp
    Talanta 204 (2019) 739–746 Contents lists available at ScienceDirect Talanta journal homepage: www.elsevier.com/locate/talanta Call it a “nightshade”—A hierarchical classification approach to T identification of hallucinogenic Solanaceae spp. using DART-HRMS-derived chemical signatures ∗ Samira Beyramysoltan, Nana-Hawwa Abdul-Rahman, Rabi A. Musah Department of Chemistry, State University of New York at Albany, 1400 Washington Ave, Albany, NY, 12222, USA ARTICLE INFO ABSTRACT Keywords: Plants that produce atropine and scopolamine fall under several genera within the nightshade family. Both Hierarchical classification atropine and scopolamine are used clinically, but they are also important in a forensics context because they are Psychoactive plants abused recreationally for their psychoactive properties. The accurate species attribution of these plants, which Seed species identifiction are related taxonomically, and which all contain the same characteristic biomarkers, is a challenging problem in Metabolome profiling both forensics and horticulture, as the plants are not only mind-altering, but are also important in landscaping as Direct analysis in real time-mass spectrometry ornamentals. Ambient ionization mass spectrometry in combination with a hierarchical classification workflow Chemometrics is shown to enable species identification of these plants. The hierarchical classification simplifies the classifi- cation problem to primarily consider the subset of models that account for the hierarchy taxonomy, instead of having it be based on discrimination between species using a single flat classification model. Accordingly, the seeds of 24 nightshade plant species spanning 5 genera (i.e. Atropa, Brugmansia, Datura, Hyocyamus and Mandragora), were analyzed by direct analysis in real time-high resolution mass spectrometry (DART-HRMS) with minimal sample preparation required.
    [Show full text]
  • The Mandrake and the Ancient World,” the Evangelical Quarterly 28.2 (1956): 87-92
    R.K. Harrison, “The Mandrake And The Ancient World,” The Evangelical Quarterly 28.2 (1956): 87-92. The Mandrake and the Ancient World R.K. Harrison [p.87] Professor Harrison, of the Department of Old Testament in Huron College, University of Western Ontario, has already shown by articles in THE EVANGELICAL QUARTERLY his interest and competence in the natural history of the Bible. Here he examines one of the more curious Biblical plants. The mandrake is one of the plants which still grows widely in the Middle East, and which has claimed magical associations from a very remote period. It is generally assigned the botanical name of Mandragora officinarum L..1 and is a perennial of the order Solanaceae. It claims affinity with the potato and eggplant, and is closely allied to the Atropa belladonna L.,2 with which it is not infrequently confused by some writers. The modern Arab knows it by a number of names, including Tuffah£ el Majanin (‘Madmen’s Apple) and Beid el Jinn (Eggs of the Jinn), apparently a reference to the ability of the plant to invigorate and stimulate the senses even to the point of mental imbalance. The former name may perhaps be a survival of the belief found in Oriental folk-lore regarding the magical herb Baaras, with which the mandrake is identified by some authorities.3 According to the legends associated with this plant, it was highly esteemed amongst the ancients on account of its pronounced magical properties. But because of the potency of these attributes it was an extremely hazardous undertaking for anyone to gather the plant, and many who attempted it were supposed to have paid for their daring with [p.88] sickness and death.4 Once the herb had been gathered, however, it availed for a number of diseases, and in antiquity it was most reputed for its ability to cure depression and general disorders of the mind.
    [Show full text]
  • KHAT Latest Revision: June 11, 2005
    KHAT Latest Revision: June 11, 2005 O CH3 NH2 Cathinone OH CH3 NH2 Cathine N CH3 H3C N 3,6-dimethyl-2,5-diphenylpyrazine (dimer of Cathinone) 1. SYNONYMS CFR: Cathinone Cathine CAS #: Cathinone Hydrochloride: 71031-15-7 Cathine Hydrochloride: 2153-98-2 Cathine Base: 492-39-7 Other Names: Catha edulis Kat Mutsawhari Mutsawari Mdimamadzi Musitate Mirungi Miraa Ol meraa Tumayot Liruti Ikwa Arabian Tea 2. CHEMICAL AND PHYSICAL DATA Khat is used as a stimulant or as a medicine in parts of Africa and the Arabian Peninsula. The plant is thought to have been in cultivation before the coffee plant; historical references date the use of the plant to the fourteenth century. Peter Forsskal, a physician and botanist, collected khat specimens in an expedition organized by the King of Denmark in the eighteenth century. Forsskal assigned the name Catha edulis to the plant. The effects produced by the drug include excitation, hypersensitivity, anorexia, insomnia, euphoria, increased respiration, and hyperthermia. These effects closely parallel the effects of d-amphetamine. Khat is a bush or tree that grows naturally in the humid mountainous regions (elevations of 5000 to 6500 feet) of East and South Africa. The trees can grow naturally to over 60 ft; however, cultivated khat trees are pruned and their height to kept to approximately 16 feet. Khat also grows to a height of 3 feet as a small bush in arid regions. Like opium, the alkaloid content of khat will vary with the soil, climatic conditions, and cultivation. Khat belongs to the genus Catha edulis. It is recognized that the genus consists of only one species; however, the plant exhibits extreme polymorphism.
    [Show full text]
  • Clandestine Drug Lab General Cleanup Guidance
    Clandestine Drug Lab General Cleanup Guidance DIVISION OF ENVIRONMENTAL HEALTH i Minnesota Department of Health (MDH) Division of Environmental Health Minnesota Pollution Control Agency (MPCA) Clandestine Drug Lab General Cleanup Guidance September 2010 VERSION, Clarification to Table 1 March 2013 FOR MORE INFORMATION, CONTACT: MINNESOTA DEPARTMENT OF HEALTH DIVISION OF ENVIRONMENTAL HEALTH PO BOX 64975 ST. PAUL, MN 55164-0975 TEL: 651-201-4899 TOLL FREE: 888-657-3908 FAX: 651-201-4606 TDD: 651-201-5797 TO REQUEST THIS DOCUMENT IN ANOTHER FORMAT, SUCH AS LARGE PRINT, BRAILLE OR CASSETTE TAPE, CALL 651-201-4911; TDD 651-201-5797 OR TOLL-FREE THROUGH THE MN RELAY SERVICE, 1-800-627-3529.TABLE OF CONTENT ii TABLE OF CONTENTS Clandestine Drug Lab .................................................................................................................. i General Cleanup ..........................................................................................................................i Guidance ..................................................................................................................................i TABLE OF CONTENTS ............................................................................................................. iii ACKNOWLEDGEMENTS ........................................................................................................... v ACKNOWLEDGEMENTS ........................................................................................................... v I. INTRODUCTION ..................................................................................................................
    [Show full text]
  • SENATE BILL No. 259 No
    SENATE BILL No. 259 SENATE BILL No. 259 March 10, 2011, Introduced by Senators JONES, CASPERSON and SCHUITMAKER and referred to the Committee on Judiciary. A bill to amend 1978 PA 368, entitled "Public health code," by amending section 7212 (MCL 333.7212), as amended by 2010 PA 171. THE PEOPLE OF THE STATE OF MICHIGAN ENACT: 1 Sec. 7212. (1) The following controlled substances are 2 included in schedule 1: 3 (a) Any of the following opiates, including their isomers, 4 esters, the ethers, salts, and salts of isomers, esters, and 5 ethers, unless specifically excepted, when the existence of these 6 isomers, esters, ethers, and salts is possible within the 7 specific chemical designation: SENATE BILL No. 259 00981'11 TLG 2 1 Acetylmethadol Difenoxin Noracymethadol 2 Allylprodine Dimenoxadol Norlevorphanol 3 Alpha-acetylmethadol Dimepheptanol Normethadone 4 Alphameprodine Dimethylthiambutene Norpipanone 5 Alphamethadol Dioxaphetyl butyrate Phenadoxone 6 Benzethidine Dipipanone Phenampromide 7 Betacetylmethadol Ethylmethylthiambutene Phenomorphan 8 Betameprodine Etonitazene Phenoperidine 9 Betamethadol Etoxeridine Piritramide 10 Betaprodine Furethidine Proheptazine 11 Clonitazene Hydroxypethidine Properidine 12 Dextromoramide Ketobemidone Propiram 13 Diampromide Levomoramide Racemoramide 14 Diethylthiambutene Levophenacylmorphan Trimeperidine 15 Morpheridine 16 (b) Any of the following opium derivatives, their salts, 17 isomers, and salts of isomers, unless specifically excepted, when 18 the existence of these salts, isomers, and salts of
    [Show full text]
  • Inventory of Toxic Plants in Morocco: an Overview of the Botanical, Biogeography, and Phytochemistry Studies
    Hindawi Journal of Toxicology Volume 2018, Article ID 4563735, 13 pages https://doi.org/10.1155/2018/4563735 Review Article Inventory of Toxic Plants in Morocco: An Overview of the Botanical, Biogeography, and Phytochemistry Studies Hanane Benzeid , Fadma Gouaz, Abba Hamadoun Touré, Mustapha Bouatia , Mohamed Oulad Bouyahya Idrissi, and Mustapha Draoui LaboratoiredeChimieAnalytiqueetdeBromatologie,FacultedeM´ edecine´ et de Pharmacie, Universite´ Mohamed V, Rabat, Morocco Correspondence should be addressed to Hanane Benzeid; [email protected] Received 10 December 2017; Revised 22 February 2018; Accepted 25 March 2018; Published 3 May 2018 Academic Editor: Orish Ebere Orisakwe Copyright © 2018 Hanane Benzeid et al. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Since they are natural, plants are wrongly considered nondangerous; therefore people used them in various contexts. Each plant is used alone or in mixture with others, where knowledge and the requirements of preparation and consumption are not mastered. Tus, intoxications due to the use of plants have become more and more frequent. Te reports of intoxications made at the Antipoison Center and Pharmacovigilance of Morocco (ACPM) support this fnding, since the interrogations sufered by the victimsshowthattheuseofplantsispracticedirrationally,anarchically, and uncontrollably. Faced by the increase of these cases of poisoning in Morocco, it seemed necessary to investigate the nature of poisonous plants, their monographs, and the chemicals responsible for this toxicity. 1. Introduction Tus, we thought it is necessary to study the nature of these poisonous plants and their monographs. Sinceimmemorialtime,thehumanhasusedplants,frstto feed himself and then to heal himself.
    [Show full text]
  • (19) United States (12) Patent Application Publication (10) Pub
    US 20130289061A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0289061 A1 Bhide et al. (43) Pub. Date: Oct. 31, 2013 (54) METHODS AND COMPOSITIONS TO Publication Classi?cation PREVENT ADDICTION (51) Int. Cl. (71) Applicant: The General Hospital Corporation, A61K 31/485 (2006-01) Boston’ MA (Us) A61K 31/4458 (2006.01) (52) U.S. Cl. (72) Inventors: Pradeep G. Bhide; Peabody, MA (US); CPC """"" " A61K31/485 (201301); ‘4161223011? Jmm‘“ Zhu’ Ansm’ MA. (Us); USPC ......... .. 514/282; 514/317; 514/654; 514/618; Thomas J. Spencer; Carhsle; MA (US); 514/279 Joseph Biederman; Brookline; MA (Us) (57) ABSTRACT Disclosed herein is a method of reducing or preventing the development of aversion to a CNS stimulant in a subject (21) App1_ NO_; 13/924,815 comprising; administering a therapeutic amount of the neu rological stimulant and administering an antagonist of the kappa opioid receptor; to thereby reduce or prevent the devel - . opment of aversion to the CNS stimulant in the subject. Also (22) Flled' Jun‘ 24’ 2013 disclosed is a method of reducing or preventing the develop ment of addiction to a CNS stimulant in a subj ect; comprising; _ _ administering the CNS stimulant and administering a mu Related U‘s‘ Apphcatlon Data opioid receptor antagonist to thereby reduce or prevent the (63) Continuation of application NO 13/389,959, ?led on development of addiction to the CNS stimulant in the subject. Apt 27’ 2012’ ?led as application NO_ PCT/US2010/ Also disclosed are pharmaceutical compositions comprising 045486 on Aug' 13 2010' a central nervous system stimulant and an opioid receptor ’ antagonist.
    [Show full text]